Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder

NCT03899194 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT03899194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03899194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder
Lead sponsor
Shanghai Mental Health Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 31, 2021
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder